8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

March 2, 2011

Date of Report (Date of earliest event reported)

EMCORE CORPORATION

Exact Name of Registrant as Specified in its Charter

New Jersey	0-22175	22-2746503
State of Incorporation	Commission File Number	IRS Employer Identification Number

10420 Research Road, SE, Albuquerque, NM  87123

Address of principal executive offices, including zip code

(505) 332-5000

Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 2, 2011, the Board of Directors of EMCORE Corporation (the “Company”) elected Dr. James  A. Tegnelia to the Board of Directors as a Class C Director.  Dr. Tegnelia’s term on the Board of Directors began on March 2, 2011 and will expire at the Company’s annual meeting of stockholders in 2012.   Dr. Tegnelia is not expected to be named at this time to any of the committees of the Board of Directors.  Dr. Tegnelia was not selected as a director pursuant to any arrangement or understanding between him and any other person.

Dr. Tegnelia will receive the standard compensation received by non-employee directors, including participation in the Directors’ Stock Award Plan and fees for attending board meetings, as described in the Company’s Form 10K/A filed with the SEC on January 28, 2011. There are no, nor have there been any, related person transactions between the Company and Dr. Tegnelia reportable under Item 404(a) of Regulation S-K.

A copy of the Company’s press release announcing this appointment is attached as Exhibit 99.1, which is incorporated herein by reference.

ITEM 9.01              Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number	Exhibit Description
99.1	Press Release, dated March 08, 2011, issued by EMCORE Corporation.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	EMCORE CORPORATION
Dated: March 08, 2011	By: /s/ Mark Weinswig Name: Mark Weinswig Title:   Chief Financial Officer

EX-99.1

EXHIBIT 99.1

PRESS RELEASE

FOR IMMEDIATE RELEASE

James A. Tegnelia Joins Board of Directors of EMCORE Corporation

ALBUQUERQUE, NM - March 8, 2011 - EMCORE Corporation (NASDAQ:EMKR - News), a leading provider of compound semiconductor-based components, subsystems, and systems for the fiber optics and solar power markets, today announced that its Board of Directors has elected Dr. James A. Tegneliato join the Board as a Class C director.

Dr. Tegnelia currently lectures at the University of New Mexico and Georgetown University and is a member of the Defense Science Board. From 2005 to 2009, Dr. Tegnelia was the Director of the Defense Threat Reduction Agency (DTRA), Fort Belvoir, VA. DTRA safeguards America’s interests from weapons of mass destruction. Prior to his selection to lead DTRA, Dr. Tegnelia was the vice president, Department of Defense Programs, Sandia National Laboratories. Dr. Tegnelia has also served as the assistant undersecretary of defense and acting deputy undersecretary of defense in the Office of the Undersecretary of Defense for Research and Engineering, where he oversaw program manager activity on the JSTARS radar and ATACMS missile, and as the deputy director and later acting director of the Defense Advanced Research Projects Agency (DARPA). Dr. Tegnelia has also held various executive leadership positions in the defense industry, including vice president of Business Development, of the Electronics Group at the Martin Marietta Corporation, executive vice president and deputy director of Sandia National Laboratories, vice president, Business Development, for the Energy and Environment Sector of Lockheed Martin Corporation, and president of Lockheed Martin Advanced Environmental Systems, Inc.

Dr. Tegnelia earned a bachelor’s degree in physics from Georgetown University, a master’s degree in engineering from George Washington University, and a Ph.D. in physics from The Catholic University of America. His awards and decorations include the Bronze Star Medal, the Civilian Meritorious Service Medal, and the Senior Executive Service Meritorious Service Award.

"We are extremely pleased and excited about Dr. Tegnelia joining our Board of Directors," commented Reuben F. Richards, Jr., EMCORE's Chairman of the Board. "We expect Dr. Tegnelia to play a significant role in EMCORE's expansion of its product portfolio in the Defense, Aerospace and Homeland Security markets.”

Dr. Tegnelia was elected to fill a Board vacancy and began service as a director immediately upon his election on March 2, 2011.  As a Class C director, he will stand for re-election at the Company’s 2012 annual meeting of shareholders.

About EMCORE

EMCORE Corporation is a leading provider of compound semiconductor-based components and subsystems for the broadband, fiber optic, satellite and terrestrial solar power markets. EMCORE's Fiber Optics unit offers optical components, subsystems and systems that enable the transmission of video, voice and data over high-capacity fiber optic cables for high-speed data and telecommunications, cable television (CATV) and fiber-to-the-premises (FTTP) networks. EMCORE's Solar Power unit provides solar products for satellite and terrestrial applications. For satellite applications, EMCORE offers high-efficiency compound semiconductor-based gallium arsenide (GaAs) solar cells, covered interconnect cells and fully integrated solar panels. For terrestrial applications, EMCORE offers concentrating photovoltaic (CPV) systems for utility scale solar applications as well as offering its high-efficiency GaAs solar cells and CPV components for use in solar power concentrator systems. For specific information about our company, our products or the markets we serve, please visit our website at www.emcore.com.

Contact:

EMCORE Corporation

Mark Weinswig

Chief Financial Officer

(505) 332-5000

investor@emcore.com

TTC Group

Victor Allgeier

(646) 290-6400

vic@ttcominc.com